BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7470196)

  • 1. Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemia.
    Stein EA; Glueck CJ; Wesselman A; Owens ER; Nichols S; Vink P
    Atherosclerosis; 1981; 38(1-2):149-64. PubMed ID: 7470196
    [No Abstract]   [Full Text] [Related]  

  • 2. Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
    Mancini M; Postiglione A; Farinaro E; Montefusco S
    Prev Med; 1983 Nov; 12(6):848-53. PubMed ID: 6676732
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypercholesterolemia.
    Kane JP; Malloy MJ
    Med Clin North Am; 1982 Mar; 66(2):537-50. PubMed ID: 7040850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
    Glueck CJ
    Prev Med; 1983 Nov; 12(6):835-47. PubMed ID: 6676731
    [No Abstract]   [Full Text] [Related]  

  • 5. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM; Lee HA
    Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
    Angelin B; Einarsson K
    Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous type II hyperlipoproteinemia treatment. Partial ileal bypass in two children.
    Balfour JF; Kim R
    JAMA; 1974 Mar; 227(10):1145-51. PubMed ID: 4359836
    [No Abstract]   [Full Text] [Related]  

  • 10. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
    Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
    Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
    Schwandt P; Richter WO; Weisweiler P; Neureuther G
    Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercholesterolemia: new values, new strategies.
    Lueg MC; Anding RH
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):112-3, 116-7, 120-2. PubMed ID: 3080456
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholestyramine: an effective, twice-daily dosage regimen.
    Blum CB; Havlik RJ; Morganroth J
    Ann Intern Med; 1976 Sep; 85(3):287-9. PubMed ID: 183576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB; Simpson HC; Slaughter P; Lousley S; Carter RD; Cobbe SM; Mann JI
    Atherosclerosis; 1984 Oct; 53(1):1-7. PubMed ID: 6388586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonprogression of coronary artery atherosclerosis in homozygous familial hypercholesterolemia after 31 months of repetitive plasma exchange.
    Stein EA; Adolph R; Rice V; Glueck CJ; Spitz HB
    Clin Cardiol; 1986 Mar; 9(3):115-9. PubMed ID: 3948445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.
    Keller C; Hailer S; Demant T; Wolfram G; Zöllner N
    Atherosclerosis; 1985 Nov; 57(2-3):225-34. PubMed ID: 4084356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advance in drug treatment of primary and familial hypercholesterolemia].
    Liu K
    Zhong Xi Yi Jie He Za Zhi; 1991 May; 11(5):315-7. PubMed ID: 1879038
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
    Glueck CJ; Tsang RC; Fallat RW; Scheel D
    Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
    Regnström J; Walldius G; Carlson LA; Nilsson J
    Atherosclerosis; 1990 May; 82(1-2):43-51. PubMed ID: 2360919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.